Cerenome (CNSY) Liabilities and Shareholders Equity (2010 - 2026)
Powered by 
Analysis
Cerenome (CNSY) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn | 10.96 Bn |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - | 4.32 Bn |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn | 9.18 Bn |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn | 5.56 Bn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 19.82 Bn |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | 2.10 Bn |
| 10 | Cerenome | 20.42 Mn | 11.83 Mn | - | 14.03 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.03 Mn |
| Mar 31, 2026 | 19.92 Mn |
| Dec 31, 2025 | 16.33 Mn |
| Sep 30, 2025 | 18.67 Mn |
| Jun 30, 2025 | 10.35 Mn |
| Mar 31, 2025 | 12.06 Mn |
| Dec 31, 2024 | 6.63 Mn |
| Sep 30, 2024 | 6.98 Mn |
| Jun 30, 2024 | 11.21 Mn |
| Mar 31, 2024 | 5.62 Mn |
| Dec 31, 2023 | 11.39 Mn |
| Sep 30, 2023 | 13.28 Mn |
| Jun 30, 2023 | 14.20 Mn |
| Mar 31, 2023 | 15.64 Mn |
| Dec 31, 2022 | 23.87 Mn |
| Sep 30, 2022 | 23.10 Mn |
| Jun 30, 2022 | 21.27 Mn |
| Mar 31, 2022 | 24.52 Mn |
| Dec 31, 2021 | 21.98 Mn |
| Sep 30, 2021 | 24.75 Mn |